Drug & supplement interaction

L-ornithine-l-aspartate + Palifermin

Palifermin brand name: Kepivance.

No Known Interaction
The bottom line No known interaction

We found no known interaction between L-ornithine-l-aspartate and Palifermin in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

L-ornithine-l-aspartate and Palifermin

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Palifermin and L-ornithine-l-aspartate in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for L-ornithine-l-aspartate at all — not against Palifermin, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

L-ornithine-l-aspartate safety at a glance

L-ornithine-l-aspa... overall Use caution Generally used under medical supervision for liver disease; self-treating serious liver problems is not advised.
Pregnancy Avoid Safety has not been established in pregnancy, so it is best avoided unless a doctor directs otherwise.
Breastfeeding Avoid There is not enough safety information during breastfeeding, so avoid unless advised by your doctor.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Palifermin and L-ornithine-l-aspartate? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What L-ornithine-l-aspartate Itself Has Been Linked To

This is not an interaction — nothing below involves Palifermin. It is the side-effect record for L-ornithine-l-aspartate on its own, from the licensed Natural Medicines monograph. If something new turns up after you add L-ornithine-l-aspartate, this list is the first place to look.

  • Cough Additional detail

    “Intravenously, L-ornithine-L-aspartate has caused cough.”

    L-ornithine-l-aspartate · Natural Medicines adverse-effect record, reported in cough.

    1 source cited
    1. 94907. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
  • Muscle pain Additional detail

    “Intravenously, L-ornithine-L-aspartate has caused muscle cramps.”

    L-ornithine-l-aspartate · Natural Medicines adverse-effect record, reported in muscle cramps.

    1 source cited
    1. 94907. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
  • Diarrhea Additional detail

    “Intravenously, L-ornithine-L-aspartate has caused nausea and vomiting, and, less frequently, diarrhea. Slowing down the rate of infusion can prevent nausea and vomiting.”

    L-ornithine-l-aspartate · Natural Medicines adverse-effect record, reported in diarrhea.

    3 sources cited
    1. 67394. Ahmad, I., Khan, A. A., Alam, A., Dilshad, A., Butt, A. K., Shafqat, F., Malik, K., and Sarwar, S. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J.Coll.Physicians Surg.Pak. 2008;18(11):684-687.
    2. 94907. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
    3. 94911. Pérez Hernández JL, Higuera de la Tijera F, Serralde-Zúñiga AE, Abdo Francis JM. Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Ann Hepatol 201
  • Vomiting / Nausea Additional detail

    Recorded for L-ornithine-l-aspartate in the same Natural Medicines adverse-effect record shown under Cough above.

Everything above comes from the Natural Medicines adverse-effect record for L-ornithine-l-aspartate — expand a row for the licensed statement it rests on. We read the ADVERSE REACTIONS section of Palifermin’s FDA label too, and the two lists don’t meaningfully overlap — which is why no Palifermin column appears here.

Everything else you take

See Every Supplement That Interacts With Palifermin

This page covers L-ornithine-l-aspartate only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Palifermin page lists 17 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Coffee Charcoal (moderate), European Mandrake (moderate), Glucomannan (moderate) and Guar Gum (moderate).

By severity: 1 major · 7 moderate · 9 minor.

From our pharmacist’s overview on the Palifermin page

“Palifermin (Kepivance) is given by IV to prevent the severe mouth sores that intensive chemotherapy can cause, most often in patients heading into a stem cell transplant, and I read its interaction list with genuine caution because of how fragile those patients already are. All 17 supplements on file act on absorption through the gut,…”

Reviewed by 2 · Jul 18, 2026

Open the Palifermin interaction page

One more smart check

Taking L-ornithine-l-aspartate as Part of a Dietary Supplement Product? Check It for Interactions

We hold 92 real supplement products containing L-ornithine-l-aspartate, each one broken down to its full ingredient list — and combination products often carry several ingredients besides L-ornithine-l-aspartate. Even though L-ornithine-l-aspartate itself has no known interaction with Palifermin, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where L-ornithine-l-aspartate and Palifermin Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement L-ornithine-l-aspartate
Steady interest

#1,413 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Palifermin
Steady interest

#1,945 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every L-ornithine-l-aspartate reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The L-ornithine-l-aspartate and Palifermin records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About L-ornithine-l-aspartate

What is L-ornithine-l-aspartate?

L-ornithine-l-aspartate
  • Liver-related brain symptoms (hepatic encephalopathy)
  • Lowering blood ammonia levels
  • Support in cirrhosis and fatty liver
  • General liver support

L-ornithine-L-aspartate (LOLA) is a combination of two amino acids studied mainly for lowering ammonia in people with liver disease and helping manage hepatic encephalopathy. There is reasonable clinical evidence for this specific medical use, but it should be used under medical supervision rather than as a casual 'liver detox' supplement. Talk to your doctor or pharmacist before using it, especially if you have liver or kidney problems.

Oral granules/powder, tablets, oral solution, and intravenous infusion (in clinical settings)

An interaction check asks whether these two react with each other — it does not ask whether L-ornithine-l-aspartate is a good idea for someone in your situation. Here is what our L-ornithine-l-aspartate record says about it on its own.

L-ornithine-l-aspartate: dosing

There is no single standardized over-the-counter dose for L-ornithine-L-aspartate, and the amounts used in studies were often given in a hospital or clinical setting. Oral and IV forms are dosed differently, and the right amount depends on the condition being treated.If you are using a supplement product, follow the directions on the label and do not exceed them.

From our L-ornithine-l-aspartate monograph — the full record covers uses, side effects and every documented interaction.

Read the full L-ornithine-l-aspartate monograph & all interactions
Medication

About Palifermin

What Is Palifermin Used For?

Brand name: Kepivance

Kepivance (palifermin) is used to decrease how often and how long severe oral mucositis — painful sores in the mouth and throat — occurs in patients with hematologic malignancies (blood cancers such as lymphoma, leukemia, or multiple myeloma) who are receiving high-dose, cell-damaging (myelotoxic) therapy before an autologous hematopoietic stem cell transplant (a transplant using the patient's own stem cells).

Kepivance is specifically indicated when the preparative chemotherapy or radiation regimen is expected to cause severe mucositis in most patients. It is not recommended for use with a high-dose melphalan conditioning regimen, and it was not found to be effective in the setting of allogeneic stem cell transplant (using a donor's cells). Its safety and effectiveness have not been established for patients with non-blood cancers (non-hematologic malignancies).

Most-Reported Side Effects for Palifermin

From FAERS, the FDA’s public side-effect reporting system (388 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Mucosal inflammation 56 reports
Febrile neutropenia 39 reports
Rash 39 reports
Stomatitis 34 reports
Erythema 28 reports
See full Palifermin drug information
Keep checking

Other Drugs & L-ornithine-l-aspartate

Browse every other medication we’ve checked against L-ornithine-l-aspartate — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

L-ornithine-l-aspartate References

The 3 references that drive our L-ornithine-l-aspartate monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Ahmad, I., Khan, A. A., Alam, A., Dilshad, A., Butt, A. K., Shafqat, F., Malik, K., and Sarwar, S. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J.Coll.Physicians Surg.Pak. 2008;18(11):684-687.
  2. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
  3. Pérez Hernández JL, Higuera de la Tijera F, Serralde-Zúñiga AE, Abdo Francis JM. Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Ann Hepatol 201

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking L-ornithine-l-aspartate and Palifermin Together: Common Questions

Is it safe to take L-ornithine-l-aspartate with Palifermin?
We do not list a known interaction between L-ornithine-l-aspartate and Palifermin. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Palifermin interact with any supplements?
Yes. Palifermin has documented interactions with 17 supplements in our database — L-ornithine-l-aspartate is not one of them. The Palifermin interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Palifermin and L-ornithine-l-aspartate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.